{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:58:24Z","timestamp":1787068704906,"version":"build-2736575974"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s43032-026-02087-7","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:46:54Z","timestamp":1774972014000},"page":"928-949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive Review on Recent Advancements in Navigating the Complexities of Polycystic Ovarian Syndrome (PCOS)"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3537-9826","authenticated-orcid":false,"given":"Muhammad Ahsan","family":"Waqar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-2168","authenticated-orcid":false,"given":"Naeem","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-8450","authenticated-orcid":false,"given":"Rabeel","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"2","key":"2087_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/nu15020295","volume":"15","author":"E Burnatowska","year":"2023","unstructured":"Burnatowska E, et al. Emotional eating and binge eating disorders and night eating syndrome in polycystic ovary syndrome\u2014a vicious circle of disease: a systematic review. Nutrients. 2023;15(2):295.","journal-title":"Nutrients"},{"issue":"2","key":"2087_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrendo.2015.230","volume":"12","author":"R Azziz","year":"2016","unstructured":"Azziz R. New insights into the genetics of polycystic ovary syndrome. Nat Rev Endocrinol. 2016;12(2):74\u20135.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2087_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708.","journal-title":"Hum Reprod Update"},{"key":"2087_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:1\u201310.","journal-title":"BMC Med"},{"issue":"2","key":"2087_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/obr.12762","volume":"20","author":"S Lim","year":"2019","unstructured":"Lim S, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339\u201352.","journal-title":"Obes Rev"},{"issue":"4","key":"2087_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"N Kakoly","year":"2018","unstructured":"Kakoly N, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455\u201367.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2087_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1(1):1\u201322.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"2087_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, et al. Obesity and the polycystic ovary syndrome. Int J Obes. 2002;26(7):883\u201396.","journal-title":"Int J Obes"},{"issue":"2","key":"2087_CR9","doi-asserted-by":"publisher","DOI":"10.4081\/jphr.2021.2240","volume":"10","author":"U Ernawati","year":"2021","unstructured":"Ernawati U, Wihastuti TA, Utami YW. Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: systematic literature review. J Public Health Res. 2021;10(2):jphr. 2021.2240.","journal-title":"J Public Health Res"},{"key":"2087_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00223-020-00742-y","volume":"107","author":"P Anagnostis","year":"2020","unstructured":"Anagnostis P, et al. Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis. Calcif Tissue Int. 2020;107:453\u201363.","journal-title":"Calcif Tissue Int"},{"key":"2087_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12903-020-01180-w","volume":"20","author":"C-z Wu","year":"2020","unstructured":"Wu C-z, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus. BMC Oral Health. 2020;20:1\u201315.","journal-title":"BMC Oral Health"},{"key":"2087_CR12","doi-asserted-by":"crossref","unstructured":"Condorelli RA, et al. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution.\u00a0Gynecol Endocrinol. 2017;33(9):665-667.","DOI":"10.1080\/09513590.2017.1342240"},{"issue":"1","key":"2087_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/1474651408101369","volume":"9","author":"N Sattar","year":"2009","unstructured":"Sattar N. PCOS, insulin resistance and long-term risks for diabetes and vascular disease. Br J Diabetes Vasc Dis. 2009;9(1):15\u20138.","journal-title":"Br J Diabetes Vasc Dis"},{"issue":"2","key":"2087_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","volume":"65","author":"TM Barber","year":"2006","unstructured":"Barber TM, et al. Obesity and polycystic ovary syndrome. Clin Endocrinol. 2006;65(2):137\u201345.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2087_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","volume":"14","author":"S Lim","year":"2013","unstructured":"Lim S, et al. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95\u2013109.","journal-title":"Obes Rev"},{"issue":"5","key":"2087_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.mcna.2008.04.008","volume":"92","author":"M Brassard","year":"2008","unstructured":"Brassard M, AinMelk Y, Baillargeon J-P. Basic infertility including polycystic ovary syndrome. Med Clin North Am. 2008;92(5):1163\u201392.","journal-title":"Med Clin North Am"},{"issue":"6","key":"2087_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/ajo.13051","volume":"59","author":"MF Costello","year":"2019","unstructured":"Costello MF, et al. A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2019;59(6):867\u201373.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2087_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11930-020-00260-w","volume":"12","author":"BK Freihart","year":"2020","unstructured":"Freihart BK, Sears MA, Meston CM. Relational and interpersonal predictors of sexual satisfaction. Curr Sex Health Rep. 2020;12:136\u201342.","journal-title":"Curr Sex Health Rep"},{"key":"2087_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-017-0834-2","volume":"19","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19:1\u201310.","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"2087_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075\u201391.","journal-title":"Hum Reprod"},{"key":"2087_CR21","doi-asserted-by":"crossref","unstructured":"Bulsara J, et al. A review: Brief insight into polycystic ovarian syndrome. Endocr Metab Sci. 2021;3:100085.","DOI":"10.1016\/j.endmts.2021.100085"},{"issue":"4","key":"2087_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021;95(4):531\u201341.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2087_CR23","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/diagnostics12102313","volume":"12","author":"E Carmina","year":"2022","unstructured":"Carmina E, Lobo RA. Comparing lean and obese PCOS in different PCOS phenotypes: Evidence that the body weight is more important than the Rotterdam phenotype in influencing the metabolic status. Diagnostics. 2022;12(10):2313.","journal-title":"Diagnostics"},{"key":"2087_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-021-01277-6","volume":"21","author":"SA Neubronner","year":"2021","unstructured":"Neubronner SA, et al. Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study. BMC Womens Health. 2021;21:1\u201312.","journal-title":"BMC Womens Health"},{"issue":"2","key":"2087_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/liv.14279","volume":"40","author":"M Sarkar","year":"2020","unstructured":"Sarkar M, et al. Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis. Liver Int. 2020;40(2):355\u20139.","journal-title":"Liver Int"},{"issue":"2","key":"2087_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cen.14704","volume":"97","author":"A Garg","year":"2022","unstructured":"Garg A, et al. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clin Endocrinol. 2022;97(2):156\u201364.","journal-title":"Clin Endocrinol"},{"key":"2087_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121069","volume":"310","author":"AA Choudhury","year":"2022","unstructured":"Choudhury AA, Rajeswari VD. Polycystic ovary syndrome (PCOS) increases the risk of subsequent gestational diabetes mellitus (GDM): a novel therapeutic perspective. Life Sci. 2022;310:121069.","journal-title":"Life Sci"},{"issue":"1","key":"2087_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/09513590.2017.1370644","volume":"34","author":"G Morgante","year":"2018","unstructured":"Morgante G, et al. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol. 2018;34(1):4\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"2087_CR29","volume":"7","author":"V Rodriguez Paris","year":"2019","unstructured":"Rodriguez Paris V, Bertoldo MJ. The mechanism of androgen actions in PCOS etiology. Med Sci. 2019;7(9):89.","journal-title":"Med Sci"},{"key":"2087_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01697-5","volume":"18","author":"I Kyrou","year":"2020","unstructured":"Kyrou I, et al. Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020;18:1\u201310.","journal-title":"BMC Med"},{"issue":"4","key":"2087_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/humupd\/dmac011","volume":"28","author":"A Bayona","year":"2022","unstructured":"Bayona A, et al. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis. Hum Reprod Update. 2022;28(4):501\u201317.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"2087_CR32","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.12998\/wjcc.v9.i12.2711","volume":"9","author":"I Ilias","year":"2021","unstructured":"Ilias I, Goulas S, Zabuliene L. Polycystic ovary syndrome: pathways and mechanisms for possible increased susceptibility to COVID-19. World J Clin Cases. 2021;9(12):2711.","journal-title":"World J Clin Cases"},{"key":"2087_CR33","doi-asserted-by":"crossref","unstructured":"Jeanes Y, et al. Binge eating behaviours and food cravings in women with polycystic ovary syndrome. Appetite. 2017;109:24\u201332.","DOI":"10.1016\/j.appet.2016.11.010"},{"issue":"9","key":"2087_CR34","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1017\/S0033291718002076","volume":"49","author":"AL Damone","year":"2019","unstructured":"Damone AL, et al. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019;49(9):1510\u201320.","journal-title":"Psychol Med"},{"issue":"1","key":"2087_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2265.2000.00884.x","volume":"52","author":"JJ Conn","year":"2000","unstructured":"Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2000;52(1):81\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2087_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00098","volume":"10","author":"T-T Huang","year":"2019","unstructured":"Huang T-T, et al. Current understanding of gut microbiota in mood disorders: an update of human studies. Front Genet. 2019;10:435190.","journal-title":"Front Genet"},{"key":"2087_CR37","doi-asserted-by":"crossref","unstructured":"Jeni A, Reddy KJ. Psycho-neuroendocrine regulation of autoimmune dysfunction in polycystic ovary syndrome. In: Reddy KJ, editor. Research methodologies and practical applications in psychoneuroimmunology. IGI Global Scientific Publishing; 2025. p. 483\u2013500.","DOI":"10.4018\/979-8-3693-7432-0.ch021"},{"key":"2087_CR38","doi-asserted-by":"publisher","first-page":"736320","DOI":"10.3389\/fmed.2021.736320","volume":"8","author":"W-Y Cai","year":"2022","unstructured":"Cai W-Y, et al. Effect of hyperinsulinemia and insulin resistance on endocrine, metabolic, and reproductive outcomes in non-PCOS women undergoing assisted reproduction: A retrospective cohort study. Front Med. 2022;8:736320.","journal-title":"Front Med"},{"key":"2087_CR39","doi-asserted-by":"publisher","unstructured":"Sharma U, et al. Journey through the gut-inflammation axis in polycystic ovary syndrome: the microbiota\u2019s role in shaping inflammatory pathways. Mol Cell Biochem. 2025(2). https:\/\/doi.org\/10.1007\/s11010-025-05409-6.","DOI":"10.1007\/s11010-025-05409-6"},{"issue":"5","key":"2087_CR40","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","volume":"109","author":"A Dokras","year":"2018","unstructured":"Dokras A, et al. Androgen excess-polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109(5):888\u201399.","journal-title":"Fertil Steril"},{"issue":"8","key":"2087_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081989","volume":"10","author":"M Jensterle","year":"2022","unstructured":"Jensterle M, Herman R, Jane\u017e A. Therapeutic potential of glucagon-like peptide-1 agonists in polycystic ovary syndrome: from current clinical evidence to future perspectives. Biomedicines. 2022;10(8):1989.","journal-title":"Biomedicines"},{"key":"2087_CR42","unstructured":"Teskey JF, Dean HJ, Sellers EA, PCOS & teens. Canadian Journal of Diagnosis 2002;61."},{"issue":"9","key":"2087_CR43","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/humrep\/del185","volume":"21","author":"V De Leo","year":"2006","unstructured":"De Leo V, et al. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod. 2006;21(9):2252\u20136.","journal-title":"Hum Reprod"},{"key":"2087_CR44","doi-asserted-by":"crossref","unstructured":"Legro RS Obesity and PCOS: implications for diagnosis and treatment. in Seminars in reproductive medicine. 2012. Thieme Medical Publishers.","DOI":"10.1055\/s-0032-1328878"},{"issue":"17","key":"2087_CR45","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.2174\/13816128112092482","volume":"18","author":"A Beatriz Motta","year":"2012","unstructured":"Beatriz Motta A. The role of obesity in the development of polycystic ovary syndrome. Curr Pharm Des. 2012;18(17):2482\u201391.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2087_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12487","volume":"21","author":"M Harada","year":"2022","unstructured":"Harada M. Pathophysiology of polycystic ovary syndrome revisited: current understanding and perspectives regarding future research. Reprod Med Biol. 2022;21(1):e12487.","journal-title":"Reprod Med Biol"},{"issue":"6","key":"2087_CR47","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1002\/jcp.27603","volume":"234","author":"H Yaribeygi","year":"2019","unstructured":"Yaribeygi H, et al. Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152\u201361.","journal-title":"J Cell Physiol"},{"key":"2087_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01688-6","volume":"18","author":"H Kolb","year":"2020","unstructured":"Kolb H, et al. Insulin: too much of a good thing is bad. BMC Med. 2020;18:1\u201312.","journal-title":"BMC Med"},{"key":"2087_CR49","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00063.2017","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018. https:\/\/doi.org\/10.1152\/physrev.00063.2017.","journal-title":"Physiol Rev"},{"issue":"6","key":"2087_CR50","first-page":"743","volume":"131","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee S, Maitra A. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res. 2010;131(6):743\u201360.","journal-title":"Indian J Med Res"},{"issue":"3","key":"2087_CR51","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1067\/mjd.2001.117430","volume":"45","author":"RL Rosenfield","year":"2001","unstructured":"Rosenfield RL. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. J Am Acad Dermatol. 2001;45(3):S95-104.","journal-title":"J Am Acad Dermatol"},{"key":"2087_CR52","doi-asserted-by":"crossref","unstructured":"Saltiel AR, Insulin signaling in the control of glucose and lipid homeostasis. Metabolic control 2016;51\u201371.","DOI":"10.1007\/164_2015_14"},{"issue":"9","key":"2087_CR53","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1210\/js.2019-00065","volume":"3","author":"DD Thomas","year":"2019","unstructured":"Thomas DD, et al. Hyperinsulinemia: an early indicator of metabolic dysfunction. J Endocr Soc. 2019;3(9):1727\u201347.","journal-title":"J Endocr Soc"},{"key":"2087_CR54","doi-asserted-by":"crossref","unstructured":"Rani R, et al. A landscape analysis of the potential role of polyphenols for the treatment of polycystic ovarian syndrome (PCOS). Phytomedicine Plus. 2022;2(1):100161.","DOI":"10.1016\/j.phyplu.2021.100161"},{"key":"2087_CR55","doi-asserted-by":"publisher","first-page":"117955811987404","DOI":"10.1177\/1179558119874042","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber TM, et al. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"02","key":"2087_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/a-1081-2036","volume":"80","author":"X Zhao","year":"2020","unstructured":"Zhao X, et al. Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review. Geburtshilfe Frauenheilkd. 2020;80(02):161\u201371.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"2087_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s13668-023-00456-1","volume":"12","author":"L Barrea","year":"2023","unstructured":"Barrea L, et al. Ketogenic diet as medical prescription in women with polycystic ovary syndrome (PCOS). Curr Nutr Rep. 2023;12(1):56\u201364.","journal-title":"Curr Nutr Rep"},{"issue":"10","key":"2087_CR58","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.3390\/nu13103526","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang Z, et al. Dietary intake, eating behavior, physical activity, and quality of life in infertile women with PCOS and obesity compared with non-PCOS obese controls. Nutrients. 2021;13(10):3526.","journal-title":"Nutrients"},{"issue":"19","key":"2087_CR59","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.3390\/ijms21197054","volume":"21","author":"A Wawrzkiewicz-Ja\u0142owiecka","year":"2020","unstructured":"Wawrzkiewicz-Ja\u0142owiecka A, et al. In search of new therapeutics\u2014molecular aspects of the PCOS pathophysiology: genetics, hormones, metabolism and beyond. Int J Mol Sci. 2020;21(19):7054.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2087_CR60","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1530\/EC-18-0141","volume":"7","author":"A Wang","year":"2018","unstructured":"Wang A, et al. Characterization of fibroblast growth factor 1 in obese children and adolescents. Endocr Connect. 2018;7(8):932\u201340.","journal-title":"Endocr Connect"},{"key":"2087_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jtemb.2017.04.008","volume":"42","author":"S Fazelian","year":"2017","unstructured":"Fazelian S, et al. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis. J Trace Elem Med Biol. 2017;42:92\u20136.","journal-title":"J Trace Elem Med Biol"},{"key":"2087_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2018.04.003","volume":"56","author":"V Maleki","year":"2018","unstructured":"Maleki V, et al. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review. Nutr Res. 2018;56:1\u201310.","journal-title":"Nutr Res"},{"issue":"5","key":"2087_CR63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520.","journal-title":"Endocr Rev"},{"issue":"9","key":"2087_CR64","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"23","key":"2087_CR65","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.3390\/ijms232314663","volume":"23","author":"D Szukiewicz","year":"2022","unstructured":"Szukiewicz D, et al. Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)\u2014searching for epigenetic factors. Int J Mol Sci. 2022;23(23):14663.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2087_CR66","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1530\/JOE-16-0449","volume":"232","author":"NM Templeman","year":"2017","unstructured":"Templeman NM, et al. A causal role for hyperinsulinemia in obesity. J Endocrinol. 2017;232(3):R173-83.","journal-title":"J Endocrinol"},{"issue":"5","key":"2087_CR67","first-page":"671","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva AA, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671\u201382.","journal-title":"Can J Cardiol"},{"issue":"4","key":"2087_CR68","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.3390\/ijms24043140","volume":"24","author":"R Herman","year":"2023","unstructured":"Herman R, et al. Insulin metabolism in polycystic ovary syndrome: secretion, signaling, and clearance. Int J Mol Sci. 2023;24(4):3140.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2087_CR69","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12020-023-03516-2","volume":"83","author":"M Sun","year":"2024","unstructured":"Sun M, et al. Androgen-induced upregulation of CFTR in pancreatic \u03b2-cell contributes to hyperinsulinemia in PCOS model. Endocrine. 2024;83(1):242\u201350.","journal-title":"Endocrine"},{"issue":"8","key":"2087_CR70","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, et al. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2087_CR71","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, et al. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261\u201371.","journal-title":"J Hum Reprod Sci"},{"issue":"7","key":"2087_CR72","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/metabo11070437","volume":"11","author":"AM Fulghesu","year":"2021","unstructured":"Fulghesu AM, et al. Urinary metabolites reveal hyperinsulinemia and insulin resistance in polycystic ovarian syndrome (PCOS). Metabolites. 2021;11(7):437.","journal-title":"Metabolites"},{"issue":"1","key":"2087_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13048-023-01334-8","volume":"17","author":"N-X Jiang","year":"2024","unstructured":"Jiang N-X, et al. Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility. J Ovarian Res. 2024;17(1):31.","journal-title":"J Ovarian Res"},{"issue":"3","key":"2087_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31083\/j.ceog5103057","volume":"51","author":"L Ram\u00edrez-Mart\u00ednez","year":"2024","unstructured":"Ram\u00edrez-Mart\u00ednez L, et al. The potential for ketogenic diets to control glucotoxicity, hyperinsulinemia, and insulin resistance to improve fertility in women with polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2024;51(3):57.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"15","key":"2087_CR75","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.3390\/jcm11154509","volume":"11","author":"G Morgante","year":"2022","unstructured":"Morgante G, et al. PCOS physiopathology and vitamin D deficiency: biological insights and perspectives for treatment. J Clin Med. 2022;11(15):4509.","journal-title":"J Clin Med"},{"issue":"1","key":"2087_CR76","first-page":"3","volume":"2","author":"MF Hassan","year":"2023","unstructured":"Hassan MF, Jawad MA, Al-yasiry RZ. Does insulin resistance (IR) have an impact on the reproductive and fertility potential in polycystic ovary syndrome (PCOS) women? Maaen J Med Sci. 2023;2(1):3.","journal-title":"Maaen J Med Sci"},{"issue":"3","key":"2087_CR77","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s43032-023-01374-x","volume":"31","author":"S Misra","year":"2024","unstructured":"Misra S, et al. Comparative study of insulin sensitivity and resistance and their correlation with androgens in lean and obese women with polycystic ovary syndrome. Reprod Sci. 2024;31(3):754\u201363.","journal-title":"Reprod Sci"},{"issue":"4","key":"2087_CR78","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/jcm10040829","volume":"10","author":"V Borzan","year":"2021","unstructured":"Borzan V, et al. Risk of insulin resistance and metabolic syndrome in women with hyperandrogenemia: a comparison between PCOS phenotypes and beyond. J Clin Med. 2021;10(4):829.","journal-title":"J Clin Med"},{"issue":"1","key":"2087_CR79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/metabo13010129","volume":"13","author":"AG Mukherjee","year":"2023","unstructured":"Mukherjee AG, et al. The implication of mechanistic approaches and the role of the microbiome in polycystic ovary syndrome (PCOS): a review. Metabolites. 2023;13(1):129.","journal-title":"Metabolites"},{"issue":"6","key":"2087_CR80","doi-asserted-by":"publisher","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","volume":"17","author":"M Dapas","year":"2020","unstructured":"Dapas M, et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis. PLoS Med. 2020;17(6):e1003132.","journal-title":"PLoS Med"},{"issue":"7","key":"2087_CR81","doi-asserted-by":"publisher","first-page":"e14117","DOI":"10.1111\/jfbc.14117","volume":"46","author":"R Shahid","year":"2022","unstructured":"Shahid R, et al. Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). J Food Biochem. 2022;46(7):e14117.","journal-title":"J Food Biochem"},{"key":"2087_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2024.100193","author":"S Lalonde-Bester","year":"2024","unstructured":"Lalonde-Bester S, et al. Prevalence and etiology of eating disorders in polycystic ovary syndrome: a scoping review. Adv Nutr. 2024. https:\/\/doi.org\/10.1016\/j.advnut.2024.100193.","journal-title":"Adv Nutr"},{"issue":"5","key":"2087_CR83","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.fertnstert.2020.01.016","volume":"113","author":"EA Greenwood","year":"2020","unstructured":"Greenwood EA, et al. Obesity and depression are risk factors for future eating disorder-related attitudes and behaviors in women with polycystic ovary syndrome. Fertil Steril. 2020;113(5):1039\u201349.","journal-title":"Fertil Steril"},{"issue":"4","key":"2087_CR84","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/jocd.14313","volume":"21","author":"M Amiri","year":"2022","unstructured":"Amiri M, et al. Prevalence of idiopathic hirsutism: A systematic review and meta-analysis. J Cosmet Dermatol. 2022;21(4):1419\u201327.","journal-title":"J Cosmet Dermatol"},{"key":"2087_CR85","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/978-3-030-84367-0_51","volume-title":"PCOS and Hirsutism. A case-based guide to clinical endocrinology","author":"SE Karakas","year":"2022","unstructured":"Karakas SE. PCOS and Hirsutism. A case-based guide to clinical endocrinology. 2022. p. 479\u201381."},{"key":"2087_CR86","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s40519-018-0533-y","volume":"24","author":"I Lee","year":"2019","unstructured":"Lee I, et al. Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis. Eat Weight Disord-Stud Anorex Bulim Obes. 2019;24:787\u201397.","journal-title":"Eat Weight Disord-Stud Anorex Bulim Obes"},{"issue":"2","key":"2087_CR87","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.fertnstert.2019.09.034","volume":"113","author":"SL Robinson","year":"2020","unstructured":"Robinson SL, et al. The associations of maternal polycystic ovary syndrome and hirsutism with behavioral problems in offspring. Fertil Steril. 2020;113(2):435\u201343.","journal-title":"Fertil Steril"},{"issue":"2","key":"2087_CR88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0015-0282(03)00734-9","volume":"80","author":"MO Goodarzi","year":"2003","unstructured":"Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril. 2003;80(2):255\u20138.","journal-title":"Fertil Steril"},{"issue":"12","key":"2087_CR89","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1210\/clinem\/dgae462","volume":"109","author":"LG Cooney","year":"2024","unstructured":"Cooney LG, et al. Increased prevalence of binge eating disorder and bulimia nervosa in women with polycystic ovary syndrome: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2024;109(12):3293\u2013305.","journal-title":"J Clin Endocrinol Metab"},{"key":"2087_CR90","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s13224-021-01510-0","volume":"71","author":"MK Seth","year":"2021","unstructured":"Seth MK, et al. Association of leptin with polycystic ovary syndrome: a systematic review and meta-analysis. J Obstetr Gynecol India. 2021;71:567\u201376.","journal-title":"J Obstetr Gynecol India"},{"key":"2087_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00890-8","volume":"21","author":"C Ee","year":"2021","unstructured":"Ee C, et al. Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success. BMC Endocr Disord. 2021;21:1\u201312.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"2087_CR92","doi-asserted-by":"publisher","first-page":"20200016","DOI":"10.1515\/hmbci-2020-0016","volume":"41","author":"M G\u00f6z\u00fck\u00fc\u00e7\u00fck","year":"2020","unstructured":"G\u00f6z\u00fck\u00fc\u00e7\u00fck M, et al. Adiponectin and leptin levels in normal weight women with polycystic ovary syndrome. Horm Mol Biol Clin Investig. 2020;41(4):20200016.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"8","key":"2087_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13575","volume":"24","author":"D Skrypnik","year":"2023","unstructured":"Skrypnik D, et al. Leptin\u2013VEGF crosstalk in excess body mass and related disorders: a systematic review. Obes Rev. 2023;24(8):e13575.","journal-title":"Obes Rev"},{"key":"2087_CR94","unstructured":"Liu Y, Ting J, Zhu W, Role of cholecystokinin in appetite regulation: A review. Octa J Biosci 2023;11(1)."},{"issue":"2","key":"2087_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13531","volume":"24","author":"MI Aukan","year":"2023","unstructured":"Aukan MI, et al. Differences in gastrointestinal hormones and appetite ratings between individuals with and without obesity\u2014a systematic review and meta-analysis. Obes Rev. 2023;24(2):e13531.","journal-title":"Obes Rev"},{"issue":"12","key":"2087_CR96","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1017\/S0007114522000381","volume":"129","author":"A Warrilow","year":"2023","unstructured":"Warrilow A, et al. Role of cholecystokinin in satiation: a systematic review and meta-analysis. Br J Nutr. 2023;129(12):2182\u201390.","journal-title":"Br J Nutr"},{"issue":"19","key":"2087_CR97","doi-asserted-by":"publisher","first-page":"9702","DOI":"10.3390\/ijms26199702","volume":"26","author":"D Koleva-Tyutyundzhieva","year":"2025","unstructured":"Koleva-Tyutyundzhieva D, et al. Metabolic and inflammatory adipokine profiles in PCOS: a focus on adiposity, insulin resistance, and atherogenic risk. Int J Mol Sci. 2025;26(19):9702.","journal-title":"Int J Mol Sci"},{"key":"2087_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1210726","volume":"10","author":"Y Guo","year":"2023","unstructured":"Guo Y, Xia Y, Chen K. The body mass index is associated with increased temporal variability of functional connectivity in brain reward system. Front Nutr. 2023;10:1210726.","journal-title":"Front Nutr"},{"key":"2087_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2022.101043","volume":"68","author":"EN Hilz","year":"2023","unstructured":"Hilz EN, Lee HJ. Estradiol and progesterone in female reward-learning, addiction, and therapeutic interventions. Front Neuroendocrinol. 2023;68:101043.","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"2087_CR100","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1017\/S0033291718004099","volume":"50","author":"S Wulff","year":"2020","unstructured":"Wulff S, et al. The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients. Psychol Med. 2020;50(2):220\u20138.","journal-title":"Psychol Med"},{"issue":"1","key":"2087_CR101","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/jcm10010119","volume":"10","author":"G Grassi","year":"2020","unstructured":"Grassi G, et al. Hyperandrogenism by liquid chromatography tandem mass spectrometry in PCOS: focus on testosterone and androstenedione. J Clin Med. 2020;10(1):119.","journal-title":"J Clin Med"},{"key":"2087_CR102","doi-asserted-by":"publisher","first-page":"104712","DOI":"10.1016\/j.appet.2020.104712","volume":"151","author":"G Mele","year":"2020","unstructured":"Mele G, et al. A broad-spectrum review on multimodal neuroimaging in bulimia nervosa and binge eating disorder. Appetite. 2020;151:104712.","journal-title":"Appetite"},{"issue":"5","key":"2087_CR103","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/ijerph19053089","volume":"19","author":"A Szeliga","year":"2022","unstructured":"Szeliga A, et al. Neuroendocrine determinants of polycystic ovary syndrome. Int J Environ Res Public Health. 2022;19(5):3089.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"2087_CR104","doi-asserted-by":"publisher","first-page":"e1558","DOI":"10.1002\/wsbm.1558","volume":"14","author":"GA Abruzzese","year":"2022","unstructured":"Abruzzese GA, et al. Hyperandrogenism and polycystic ovary syndrome: effects in pregnancy and offspring development. WIREs Mech Dis. 2022;14(5):e1558.","journal-title":"WIREs Mech Dis"},{"issue":"6","key":"2087_CR105","first-page":"1099","volume":"105","author":"A Sharma","year":"2021","unstructured":"Sharma A, Welt CK. Practical approach to hyperandrogenism in women. Med Clin. 2021;105(6):1099\u2013116.","journal-title":"Med Clin"},{"issue":"10","key":"2087_CR106","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s12098-023-04678-7","volume":"90","author":"V Yadav","year":"2023","unstructured":"Yadav V, Sharma Y. Hyperandrogenism. Indian J Pediatr. 2023;90(10):1018\u201324.","journal-title":"Indian J Pediatr"},{"issue":"1","key":"2087_CR107","first-page":"22","volume":"3","author":"SA Kanbour","year":"2022","unstructured":"Kanbour SA, Dobs AS. Hyperandrogenism in women with polycystic ovarian syndrome: pathophysiology and controversies. Androgens: Clinical Research and Therapeutics. 2022;3(1):22\u201330.","journal-title":"Androgens: Clinical Research and Therapeutics"},{"issue":"1","key":"2087_CR108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41398-021-01249-2","volume":"11","author":"AE de Wit","year":"2021","unstructured":"de Wit AE, et al. Plasma androgens and the presence and course of depression in a large cohort of women. Transl Psychiatry. 2021;11(1):124.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"2087_CR109","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/scientificamerican1178-154","volume":"239","author":"A Routtenberg","year":"1978","unstructured":"Routtenberg A. The reward system of the brain. Sci Am. 1978;239(5):154\u201365.","journal-title":"Sci Am"},{"key":"2087_CR110","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-29223-2","volume-title":"Managing women\u2019s hyperandrogenism","author":"M Stracquadanio","year":"2020","unstructured":"Stracquadanio M. Managing women\u2019s hyperandrogenism. Springer; 2020."},{"issue":"21","key":"2087_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218191","volume":"21","author":"X Qu","year":"2020","unstructured":"Qu X, Donnelly R. Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int J Mol Sci. 2020;21(21):8191.","journal-title":"Int J Mol Sci"},{"key":"2087_CR112","doi-asserted-by":"crossref","unstructured":"Guo J, et al. Gut microbiota in patients with polycystic ovary syndrome: a systematic review. Reproductive Sci 2022;1\u201315.","DOI":"10.1007\/s43032-020-00430-0"},{"issue":"4","key":"2087_CR113","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/07315724.2019.1657515","volume":"39","author":"G Yurtda\u015f","year":"2020","unstructured":"Yurtda\u015f G, Akdevelio\u011flu Y. A new approach to polycystic ovary syndrome: the gut microbiota. J Am Coll Nutr. 2020;39(4):371\u201382.","journal-title":"J Am Coll Nutr"},{"issue":"1","key":"2087_CR114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/EC-19-0522","volume":"9","author":"L Zhou","year":"2020","unstructured":"Zhou L, et al. Characteristic gut microbiota and predicted metabolic functions in women with PCOS. Endocr Connect. 2020;9(1):63\u201373.","journal-title":"Endocr Connect"},{"key":"2087_CR115","doi-asserted-by":"crossref","unstructured":"Liang Z, et al. Gut microbiota alterations reveal potential gut\u2013brain axis changes in polycystic ovary syndrome. J Endocrinological Investigation 2021;1\u201311.","DOI":"10.1007\/s40618-020-01481-5"},{"key":"2087_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115150","volume":"165","author":"W Song","year":"2023","unstructured":"Song W, Yue Y, Zhang Q. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: a review. Biomed Pharmacother. 2023;165:115150.","journal-title":"Biomed Pharmacother"},{"key":"2087_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1142041","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, et al. Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications. Front Cell Infect Microbiol. 2023;13:1142041.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2087_CR118","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","volume":"13","author":"F-f He","year":"2020","unstructured":"He F-f, Li Y-m. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73.","journal-title":"J Ovarian Res"},{"issue":"11","key":"2087_CR119","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1139\/cjpp-2019-0413","volume":"98","author":"Y Liang","year":"2020","unstructured":"Liang Y, et al. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity\u2014a preliminary report. Can J Physiol Pharmacol. 2020;98(11):803\u20139.","journal-title":"Can J Physiol Pharmacol"},{"issue":"50","key":"2087_CR120","doi-asserted-by":"publisher","first-page":"e36075","DOI":"10.1097\/MD.0000000000036075","volume":"102","author":"H Guo","year":"2023","unstructured":"Guo H, Luo J, Lin H. Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: a review. Medicine. 2023;102(50):e36075.","journal-title":"Medicine"},{"key":"2087_CR121","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3389\/fmed.2022.813204","volume":"9","author":"L Mitrea","year":"2022","unstructured":"Mitrea L, et al. Guts imbalance imbalances the brain: a review of gut microbiota association with neurological and psychiatric disorders. Front Med. 2022;9:706.","journal-title":"Front Med"},{"issue":"1","key":"2087_CR122","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41522-021-00231-6","volume":"7","author":"F Chen","year":"2021","unstructured":"Chen F, et al. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients. npj Biofilms Microbiomes. 2021;7(1):60.","journal-title":"npj Biofilms Microbiomes"},{"key":"2087_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102884","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data. EClinicalMedicine. 2024. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102884.","journal-title":"EClinicalMedicine"},{"issue":"23","key":"2087_CR124","first-page":"25","volume":"6","author":"T Piri-Gharaghie","year":"2021","unstructured":"Piri-Gharaghie T. Polycystic ovary syndrome and genetic factors influencing its development: a review article. Personalized Med J. 2021;6(23):25\u20139.","journal-title":"Personalized Med J"},{"issue":"11","key":"2087_CR125","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, et al. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439\u201373.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"2087_CR126","doi-asserted-by":"publisher","first-page":"e1577","DOI":"10.1210\/clinem\/dgab838","volume":"107","author":"J Zhu","year":"2022","unstructured":"Zhu J, et al. Evidence from men for ovary-independent effects of genetic risk factors for polycystic ovary syndrome. J Clin Endocrinol Metab. 2022;107(4):e1577-87.","journal-title":"J Clin Endocrinol Metab"},{"key":"2087_CR127","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11681","author":"J Singh","year":"2020","unstructured":"Singh J, et al. Metabolic, hormonal, immunologic, and genetic factors associated with the incidence of thyroid disorders in polycystic ovarian syndrome patients. Cureus. 2020. https:\/\/doi.org\/10.7759\/cureus.11681.","journal-title":"Cureus"},{"issue":"11","key":"2087_CR128","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/metabo10110439","volume":"10","author":"R Herman","year":"2020","unstructured":"Herman R, et al. Genetic variability in antioxidative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome. Metabolites. 2020;10(11):439.","journal-title":"Metabolites"},{"issue":"3","key":"2087_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030540","volume":"10","author":"H Nautiyal","year":"2022","unstructured":"Nautiyal H, et al. Polycystic ovarian syndrome: a complex disease with a genetics approach. Biomedicines. 2022;10(3):540.","journal-title":"Biomedicines"},{"issue":"3","key":"2087_CR130","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s43032-021-00515-4","volume":"29","author":"V Bruni","year":"2022","unstructured":"Bruni V, Capozzi A, Lello S. The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art. Reprod Sci. 2022;29(3):668\u201379.","journal-title":"Reprod Sci"},{"issue":"10","key":"2087_CR131","first-page":"1609","volume":"47","author":"A Khazamipour","year":"2018","unstructured":"Khazamipour A, Nejatizadeh A, Tasnim EE. The role of INSR & diabetes in polycystic ovarian syndrome. Iran J Public Health. 2018;47(10):1609\u201310.","journal-title":"Iran J Public Health"},{"key":"2087_CR132","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1155\/2021\/7781823","volume":"2021","author":"Z Shaaban","year":"2021","unstructured":"Shaaban Z, et al. Pathophysiologic mechanisms of insulin secretion and signaling-related genes in etiology of polycystic ovary syndrome. Genet Res. 2021;2021:e4.","journal-title":"Genet Res"},{"key":"2087_CR133","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/49109","author":"U Unluturk","year":"2007","unstructured":"Unluturk U, et al. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-\u03b3. PPAR Res. 2007. https:\/\/doi.org\/10.1155\/2007\/49109.","journal-title":"PPAR Res"},{"issue":"3","key":"2087_CR134","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5493\/wjem.v13.i3.7","volume":"13","author":"IG Lempesis","year":"2023","unstructured":"Lempesis IG, Georgakopoulou VE. Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus. World J Exp Med. 2023;13(3):7.","journal-title":"World J Exp Med"},{"key":"2087_CR135","first-page":"174550572211179","volume":"18","author":"H Islam","year":"2022","unstructured":"Islam H, et al. An update on polycystic ovary syndrome: a review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Womens Health. 2022;18:17455057221117966.","journal-title":"Womens Health"},{"issue":"3","key":"2087_CR136","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/ijerph19031336","volume":"19","author":"J Parker","year":"2022","unstructured":"Parker J, et al. Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment. Int J Environ Res Public Health. 2022;19(3):1336.","journal-title":"Int J Environ Res Public Health"},{"issue":"16","key":"2087_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25169037","volume":"25","author":"K-J Chang","year":"2024","unstructured":"Chang K-J, Chen J-H, Chen K-H. The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: a molecular and cellular review of the literature. Int J Mol Sci. 2024;25(16):9037.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2087_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041454","volume":"12","author":"S Singh","year":"2023","unstructured":"Singh S, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454.","journal-title":"J Clin Med"},{"issue":"4","key":"2087_CR139","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4274\/jtgga.galenos.2019.2018.0142","volume":"20","author":"C Kshetrimayum","year":"2019","unstructured":"Kshetrimayum C, et al. Polycystic ovarian syndrome: environmental\/occupational, lifestyle factors; an overview. J Turk Ger Gynecol Assoc. 2019;20(4):255.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"2087_CR140","doi-asserted-by":"publisher","first-page":"103852","DOI":"10.1016\/j.critrevonc.2022.103852","volume":"180","author":"HT Pk","year":"2022","unstructured":"Pk HT, et al. The epigenetic correlation among ovarian cancer, endometriosis and PCOS: a review. Crit Rev Oncol Hematol. 2022;180:103852.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2087_CR141","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o348","author":"T Haseler","year":"2022","unstructured":"Haseler T, Haseler C. Lack of physical activity is a global problem. BMJ. 2022. https:\/\/doi.org\/10.1136\/bmj.o348.","journal-title":"BMJ"},{"issue":"5","key":"2087_CR142","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41574-024-00963-3","volume":"20","author":"RE Campbell","year":"2024","unstructured":"Campbell RE. Beyond the ovary: rewiring our perspective on polycystic ovary syndrome. Nat Rev Endocrinol. 2024;20(5):257\u2013257.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2087_CR143","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cen.14757","volume":"97","author":"AE Joham","year":"2022","unstructured":"Joham AE, et al. Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome. Clin Endocrinol. 2022;97(2):165\u201373.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"2087_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081912","volume":"13","author":"M Palumbo","year":"2025","unstructured":"Palumbo M, et al. PCOS and the genome: is the genetic puzzle still worth solving? Biomedicines. 2025;13(8):1912.","journal-title":"Biomedicines"},{"issue":"9","key":"2087_CR145","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","volume":"14","author":"M Siamashvili","year":"2021","unstructured":"Siamashvili M, Davis SN. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. Expert Rev Clin Pharmacol. 2021;14(9):1081\u20139.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2087_CR146","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3094642","author":"Y-S Lee","year":"2016","unstructured":"Lee Y-S, Jun H-S. Anti-inflammatory effects of GLP-1-based therapies beyond glucose control. Mediators Inflamm. 2016. https:\/\/doi.org\/10.1155\/2016\/3094642.","journal-title":"Mediators Inflamm"},{"issue":"12","key":"2087_CR147","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1097\/MS9.0000000000004189","volume":"87","author":"AS Alfaiz","year":"2025","unstructured":"Alfaiz AS. GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review. Ann Med Surg. 2025;87(12):8597\u2013603.","journal-title":"Ann Med Surg"},{"key":"2087_CR148","doi-asserted-by":"crossref","unstructured":"Khamis NH, et al. The role of AMP-activated protein kinase (AMPK) in pathogenesis of polycystic ovary syndrome. Minia J Medical Res. 2023;34(3):47\u201356.","DOI":"10.21608\/mjmr.2023.211602.1399"},{"issue":"2","key":"2087_CR149","first-page":"187","volume":"8","author":"R Dumitrescu","year":"2015","unstructured":"Dumitrescu R, et al. Metformin-clinical pharmacology in PCOs. J Med Life. 2015;8(2):187.","journal-title":"J Med Life"},{"key":"2087_CR150","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000341837","volume":"40","author":"R Pasquali","year":"2013","unstructured":"Pasquali R, Gambineri A. Insulin sensitizers in polycystic ovary syndrome. Polycystic Ovary Syndrome. 2013;40:83\u2013102.","journal-title":"Polycystic Ovary Syndrome"},{"key":"2087_CR151","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8671762","author":"R Lauretta","year":"2016","unstructured":"Lauretta R, et al. Insulin-sensitizers, polycystic ovary syndrome and gynaecological cancer risk. Int J Endocrinol. 2016. https:\/\/doi.org\/10.1155\/2016\/8671762.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"2087_CR152","volume":"2","author":"NP Johnson","year":"2014","unstructured":"Johnson NP. Metformin use in women with polycystic ovary syndrome. Ann Transl Med. 2014;2(6):56.","journal-title":"Ann Transl Med"},{"issue":"4","key":"2087_CR153","first-page":"165","volume":"10","author":"L Cassidy-Vu","year":"2016","unstructured":"Cassidy-Vu L, Joe E, Kirk JK. Role of statin drugs for polycystic ovary syndrome. J Family Reprod Health. 2016;10(4):165.","journal-title":"J Family Reprod Health"},{"issue":"1","key":"2087_CR154","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1210\/jc.2008-1750","volume":"94","author":"T Sathyapalan","year":"2009","unstructured":"Sathyapalan T, et al. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. J Clin Endocrinol Metab. 2009;94(1):103\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2087_CR155","doi-asserted-by":"crossref","unstructured":"Akre S, et al. Recent advances in the management of polycystic ovary syndrome: a review article. Cureus 2022;14(8).","DOI":"10.7759\/cureus.27689"},{"key":"2087_CR156","doi-asserted-by":"crossref","unstructured":"Seyam E, et al. Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome. Gynecological Endocrinol 2018;34(7).","DOI":"10.1080\/09513590.2017.1418853"},{"issue":"12","key":"2087_CR157","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1176\/appi.ajp.20220267","volume":"179","author":"CM Grilo","year":"2022","unstructured":"Grilo CM, et al. Naltrexone-bupropion and behavior therapy, alone and combined, for binge-eating disorder: randomized double-blind placebo-controlled trial. Am J Psychiatry. 2022;179(12):927\u201337.","journal-title":"Am J Psychiatry"},{"key":"2087_CR158","doi-asserted-by":"crossref","unstructured":"Wang GeneJack WG, et al. Effect of combined naltrexone and bupropion therapy on the brain's functional connectivity. 2018.","DOI":"10.1038\/s41366-018-0040-2"},{"issue":"1","key":"2087_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01339-y","volume":"23","author":"J Duah","year":"2025","unstructured":"Duah J, Seifer DB. Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. Reprod Biol Endocrinol. 2025;23(1):2.","journal-title":"Reprod Biol Endocrinol"},{"key":"2087_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12978-021-01073-3","volume":"18","author":"P Merviel","year":"2021","unstructured":"Merviel P, et al. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reprod Health. 2021;18:1\u20138.","journal-title":"Reprod Health"},{"issue":"1","key":"2087_CR161","doi-asserted-by":"publisher","first-page":"2301554","DOI":"10.1080\/09513590.2023.2301554","volume":"40","author":"I Lete","year":"2024","unstructured":"Lete I, et al. Update on the combination of myo-inositol\/d-chiro-inositol for the treatment of polycystic ovary syndrome. Gynecol Endocrinol. 2024;40(1):2301554.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"2087_CR162","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","volume":"109","author":"V Fitz","year":"2024","unstructured":"Fitz V, et al. Inositol for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 update of the international evidence-based PCOS guidelines. J Clin Endocrinol Metab. 2024;109(6):1630\u201355.","journal-title":"J Clin Endocrinol Metab"},{"key":"2087_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102927","author":"H Teede","year":"2024","unstructured":"Teede H, et al. International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women\u2019s health condition. EClinicalMedicine. 2024. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102927.","journal-title":"EClinicalMedicine"},{"key":"2087_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2025.05.038","author":"J Cheshire","year":"2025","unstructured":"Cheshire J, et al. Preconception and first-trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025. https:\/\/doi.org\/10.1016\/j.ajog.2025.05.038.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2087_CR165","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.eprac.2023.09.004","volume":"30","author":"CR Leal","year":"2024","unstructured":"Leal CR, et al. Assisted reproductive technology in the presence of polycystic ovary syndrome: current evidence and knowledge gaps. Endocr Pract. 2024;30(1):64\u20139.","journal-title":"Endocr Pract"},{"key":"2087_CR166","unstructured":"Pkhaladze L, et al. Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Europ Re Med Pharmacological Sci 2021;25(23)."},{"issue":"3","key":"2087_CR167","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/09513590.2018.1540578","volume":"35","author":"F Facchinetti","year":"2019","unstructured":"Facchinetti F, et al. Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials. Gynecol Endocrinol. 2019;35(3):198\u2013206.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2087_CR168","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1933719117711262","volume":"25","author":"V Tagliaferri","year":"2018","unstructured":"Tagliaferri V, et al. Melatonin treatment may be able to restore menstrual cyclicity in women with PCOS: a pilot study. Reprod Sci. 2018;25(2):269\u201375.","journal-title":"Reprod Sci"},{"issue":"4","key":"2087_CR169","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS L\u00f8vvik","year":"2019","unstructured":"L\u00f8vvik TS, et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(4):256\u201366.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2087_CR170","doi-asserted-by":"publisher","first-page":"hoy021","DOI":"10.1093\/hropen\/hoy021","volume":"2019","author":"M Costello","year":"2019","unstructured":"Costello M, et al. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Hum Reprod Open. 2019;2019(1):hoy021.","journal-title":"Hum Reprod Open"},{"issue":"9","key":"2087_CR171","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"5","key":"2087_CR172","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/cen.13304","volume":"86","author":"V Tagliaferri","year":"2017","unstructured":"Tagliaferri V, et al. Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study. Clin Endocrinol. 2017;86(5):725\u201330.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2087_CR173","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1210\/jc.2017-01739","volume":"103","author":"P-K Yang","year":"2018","unstructured":"Yang P-K, et al. The efficacy of 24-month metformin for improving menses, hormones, and metabolic profiles in polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103(3):890\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2087_CR174","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12905-022-01661-w","volume":"22","author":"H Li","year":"2022","unstructured":"Li H, Liu M, Zhang C. Women with polycystic ovary syndrome (PCOS) have reduced melatonin concentrations in their follicles and have mild sleep disturbances. BMC Womens Health. 2022;22(1):79.","journal-title":"BMC Womens Health"},{"key":"2087_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-021-00586-9","volume":"18","author":"M Alizadeh","year":"2021","unstructured":"Alizadeh M, et al. Metabolic and hormonal effects of melatonin and\/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Nutr Metab. 2021;18:1\u201311.","journal-title":"Nutr Metab"},{"key":"2087_CR176","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jad.2019.02.066","volume":"250","author":"A Shabani","year":"2019","unstructured":"Shabani A, et al. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Affect Disord. 2019;250:51\u20136.","journal-title":"J Affect Disord"},{"issue":"3","key":"2087_CR177","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","volume":"3","author":"LGE Hanem","year":"2019","unstructured":"Hanem LGE, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166\u201374.","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"2087_CR178","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.18203\/2320-1770.ijrcog20175010","volume":"6","author":"A Choudhary","year":"2017","unstructured":"Choudhary A, Jain S, Chaudhari P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence. Int J Reprod Contracept Obstet Gynecol. 2017;6(11):4971\u20135.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"2087_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-021-01252-1","volume":"21","author":"S Arentz","year":"2021","unstructured":"Arentz S, et al. Perceptions and experiences of lifestyle interventions in women with polycystic ovary syndrome (PCOS), as a management strategy for symptoms of PCOS. BMC Womens Health. 2021;21:1\u20138.","journal-title":"BMC Womens Health"},{"key":"2087_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-019-0434-8","volume":"19","author":"S Lim","year":"2019","unstructured":"Lim S, et al. Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study. BMC Endocr Disord. 2019;19:1\u20139.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2087_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02732-2","volume":"23","author":"BC Sydora","year":"2023","unstructured":"Sydora BC, et al. Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care. BMC Womens Health. 2023;23(1):569.","journal-title":"BMC Womens Health"},{"issue":"1","key":"2087_CR182","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01734-w","volume":"22","author":"M Ismayilova","year":"2022","unstructured":"Ismayilova M, Yaya S. What can be done to improve polycystic ovary syndrome (PCOS) healthcare? Insights from semi-structured interviews with women in Canada. BMC Womens Health. 2022;22(1):157.","journal-title":"BMC Womens Health"},{"issue":"1","key":"2087_CR183","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12905-022-01630-3","volume":"22","author":"M Ismayilova","year":"2022","unstructured":"Ismayilova M, Yaya S. \u201cI felt like she didn\u2019t take me seriously\u201d: a multi-methods study examining patient satisfaction and experiences with polycystic ovary syndrome (PCOS) in Canada. BMC Womens Health. 2022;22(1):47.","journal-title":"BMC Womens Health"},{"issue":"3","key":"2087_CR184","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.pec.2021.05.038","volume":"105","author":"T Copp","year":"2022","unstructured":"Copp T, et al. The challenges with managing polycystic ovary syndrome: a qualitative study of women\u2019s and clinicians\u2019 experiences. Patient Educ Couns. 2022;105(3):719\u201325.","journal-title":"Patient Educ Couns"},{"issue":"694","key":"2087_CR185","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.3399\/bjgp20X708881","volume":"70","author":"SC Hillman","year":"2020","unstructured":"Hillman SC, et al. Women\u2019s experiences of diagnosis and management of polycystic ovary syndrome: a mixed-methods study in general practice. Br J Gen Pract. 2020;70(694):e322\u20139.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"2087_CR186","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/inthealth\/ihac028","volume":"15","author":"M Ismayilova","year":"2023","unstructured":"Ismayilova M, Yaya S. \u2018I\u2019m usually being my own doctor\u2019: women\u2019s experiences of managing polycystic ovary syndrome in Canada. Int Health. 2023;15(1):56\u201366.","journal-title":"Int Health"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02087-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02087-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02087-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:06:34Z","timestamp":1780387594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02087-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":186,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02087-7","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N.A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB Approval"}},{"value":"The authors declare no competing financial interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}